NAMPT and diabetes mellitus: A variety of inflammatory processes and systematic disorders have been associated with the upregulated expression of visfatin, such as sepsis [44], inflammatory bowel diseases [45], rheumatoid arthritis [46], diabetes [47], as well as cardiovascular diseases [48].